Studies&Me to personalize treatment development as Europe’s First Virtual CRO

After four years, LEO Innovation Lab launches Studies&Me® as an independent Virtual Contract Research Organisation, gathering all stakeholders in treatment development under one roof to set new standards for clinical research.

From within LEO Innovation Lab, Studies&Me set out to change this four years ago. Since then, Studies&Me has been working on digitizing the clinical research process across all stages from recruitment to trial completion by exploring, testing, and validating new methods for conducting smarter, faster, and more accessible clinical trials. Now, Studies&Me is ready to come into its own as Europe’s first virtual contract research organisation, gathering all stakeholders under one roof, including its own investigators in an online hospital setup.

“We believe the future of clinical research is patient- and data-driven. We want to personalize treatment development by turning clinical operations upside down to ensure that the trial design and technology fit into the everyday life of the patient - not the other way around. With this approach, and in close collaboration with leading physicians, we can accelerate treatment development and achieve clinical research of higher data quality by leveraging real world data from the patients, using devices they already have at their disposal at home, such as their smartphone. This will also provide the treating physician a unique opportunity to follow their patient in real time,” says John Zibert, CEO at Studies&Me and former Chief Medical Officer at LEO Innovation Lab.